within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DB02_Cefaloridine;

model Cefaloridine
  extends Pharmacolibrary.Drugs.ATC.J.J01DB02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01DB02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cefaloridine is a first-generation cephalosporin antibiotic, previously used to treat bacterial infections such as urinary tract, respiratory, and other systemic infections. Its clinical use has been discontinued or severely restricted in most countries due to reported nephrotoxicity.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult subjects after single intravenous injection.</p><h4>References</h4><ol><li><p>van Duin, D, &amp; Bonomo, RA (2016). Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 63(2) 234–241. DOI:<a href=\"https://doi.org/10.1093/cid/ciw243\">10.1093/cid/ciw243</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27098166/\">https://pubmed.ncbi.nlm.nih.gov/27098166</a></p></li><li><p>Telles, JP, et al., &amp; Tuon, FF (2023). Optimization of Antimicrobial Stewardship Programs Using Therapeutic Drug Monitoring and Pharmacokinetics-Pharmacodynamics Protocols: A Cost-Benefit Review. <i>Therapeutic drug monitoring</i> 45(2) 200–208. DOI:<a href=\"https://doi.org/10.1097/FTD.0000000000001067\">10.1097/FTD.0000000000001067</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36622029/\">https://pubmed.ncbi.nlm.nih.gov/36622029</a></p></li><li><p>Zhanel, GG, et al., &amp; Karlowsky, JA (2019). Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. <i>Drugs</i> 79(3) 271–289. DOI:<a href=\"https://doi.org/10.1007/s40265-019-1055-2\">10.1007/s40265-019-1055-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30712199/\">https://pubmed.ncbi.nlm.nih.gov/30712199</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Cefaloridine;
